Latest News
Latest News
Today’s top news highlights: ACE inhibitors in COVID patients, fewer AMI admissions, and more
Older patients with COVID-19 had a lower risk of developing severe illness if they were taking ACE inhibitors in a new study.
News from the FDA/CDC
Many clinicians still not asking about postpartum depression
Groups at higher risk included teens, smokers, those of American Indian or Alaska Native ethnicity, those with perinatal depression, or whose...
Feature
ACE inhibitors and severe COVID-19: Protective in older patients?
A randomized trial is planned after a study showed that fewer older hypertensive patients taking ACE inhibitors were hospitalized with COVID-19....
From the Journals
As visits for AMI drop during pandemic, deaths rise
From the Journals
Extremely preterm infants fare better with corticosteroid and magnesium combo
Rates of death were lower in children exposed to both corticosteroids and magnesium sulfate, compared with one therapy or none.
Latest News
Today’s top news highlights: COVID-19 vaccine hurdles, new options in prostate cancer
Vaccine-induced neutralizing antibodies may not be enough to provide sustained protection agains the coronavirus.
From the Journals
COVID-19 may cause subacute thyroiditis
News
AHA offers advice on prehospital acute stroke triage amid COVID-19
A key goal is to ensure timely transfer of patients while minimizing the risk of infectious exposure for EMS personnel, coworkers, and other...
Latest News
COVID-19: Delirium first, depression, anxiety, insomnia later?
"We need to research which factors may contribute to enduring mental health problems, and develop interventions to prevent and treat them," said...
From the Journals
Pedometer use improves postcesarean mobility for high-risk patients
Women in the pedometer group reported improved physical and mental postpartum recovery and higher levels of satisfaction with their delivery...
Conference Coverage
BMD preserved with investigational drug for uterine fibroid bleeding
Two phase 3, randomized trials in women with uterine fibroids and heavy menstrual bleeding enrolled almost 800 women.